Vardenafil HCl Articles
Study finds "Big Pharma" fails at self-policing ED drug advertising
18 February 2013
Bayer launches orodispersible ED treatment in the UK; hit with gender discrimination suit in USA
22 March 2011
Bayer submits new Levitra formulation in EU
19 August 2009
Levitra extends erection time up to three times
30 March 2009
ED drugmakers accused of price-fixing in Switzerland
16 February 2009
Warning on ED drug-drug interactions
19 January 2009
Bayer signs deal for ProStrakan's Tostrex
15 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
US FTC closes, freezes assets of vast drug spam e-mail network
27 October 2008
Stock Commentary - Europe - week to Aug 4, 2008
11 August 2008
Lilly's 2nd-qtr rise hides coming challenges
4 August 2008
Levitra benefits prostatectomy patients
4 August 2008
Lilly has good 1Q sales but still disappoints
28 April 2008
Levitra helps ED patients with high cholesterol
31 March 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Bayer AG
17 December 2007
Lilly Japan moves into GP market with Cialis
1 October 2007
GSK returns rights to Futura Medical's ED gel
21 May 2007
Bayer Schering reports strong data on Levitra at EAU
26 March 2007
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Levitra effective in ED in men with CV disease
13 November 2006
Part D effect on US drug prices: up or down?
3 July 2006
Bayer AG sees record-breaking 1st qtr with EBIT up 8.2% to $1.56 billion on strong health care sales
8 May 2006
Bayer's Levitra improves erections 81%
10 April 2006
Bayer's income reaches 1.59B in 2005, up 133%
13 March 2006
Jerry Hall to front Bayer's ED awareness campaign
5 December 2005
Dong-A's ED drug cleared in Korea
5 December 2005
US FDA posts DSOB meeting summary
15 August 2005
US FDA calls for ED drug vision warning
18 July 2005
Improved erections up to 10 hours with Levitra
18 July 2005
House votes US federal funding ban on ED drugs
4 July 2005
FDA assesses ED drug link to blindness
6 June 2005
Stock Commentary - European
17 January 2005
Positive new data for Bayer/GSK's Levitra
20 December 2004
Bayer and GlaxoSmithKline launch ED campaign
13 December 2004
Bayer and Schering-Plough form strategic pharmaceuticals alliance
20 September 2004
Bayer sees shares dip on mixed 2nd-qtr
6 September 2004
Lilly ICOS claims increased market share for Cialis
30 August 2004
Bayer/GSK's Levitra available in Japan
21 June 2004
Levitra of benefit to diabetic men
14 June 2004
Lilly ICOS' Cialis gaining US ED market share
7 June 2004
Bayer/GSK's Levitra takes 3rd place in UK
3 May 2004
Bayer Spanish unit profits soar 275%
3 May 2004
Lilly sees sales climb 17% for 1st-qtr 2004
26 April 2004
USA's Brand Institute opens European office
19 April 2004
Levitra enhances self-esteem in ED patients
29 March 2004
Lilly's Cialis bites into Viagra's market share
29 March 2004
Thumbs-up for Viagra in ED treatment survey
29 March 2004
94% of Levitra users "satisfied," survey shows
15 March 2004
New data for Bayer/GSK's Levitra
8 March 2004
New data for Bayer/GSK's Levitra
1 March 2004
New Chemical Entities in 2003
19 January 2004
NDAs rise 20% as R&D, marketing unite: study
22 December 2003
Bayer to float chemicals unit; to focus on health care
17 November 2003
Stock Commentary - New York
3 November 2003
As R&D and marketing unite, NME numbers rise: study
3 November 2003
Impotence drugs selling fast in South Korea
27 October 2003
New data for Bayer AG/GSK's Levitra
20 October 2003
Levitra works in broad range of patients
13 October 2003
Stock Commentary - Europe
13 October 2003
Stock Commentary - Europe
6 October 2003
Cellegy issued patent for female sexual dysfunction therapy method
8 September 2003
American football hero Montana backs Novartis' Lotrel
8 September 2003
Stock Commentary - New York
8 September 2003
Bayer's profits tumble in second quarter
11 August 2003
Stock Commentary - Europe
14 July 2003
Levitra improves erection in 90%
7 July 2003
Bayer/GSK's Levitra closer to US approval
9 June 2003
Profits up at Bayer on acquisition benefits
12 May 2003
Levitra effect seen in 16 minutes
5 May 2003
GSK faces challenging times, says Wood Mackenzie
21 April 2003
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
